Todd C Brady - Net Worth and Insider Trading
Todd C Brady Net Worth
The estimated net worth of Todd C Brady is at least $8 Million dollars as of 2023-09-30. Todd C Brady is the President and CEO of Aldeyra Therapeutics Inc and owns about 1,216,535 shares of Aldeyra Therapeutics Inc (ALDX) stock worth over $8 Million. Details can be seen in Todd C Brady's Latest Holdings Summary section.
Transaction Summary of Todd C Brady
Todd C Brady Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Todd C Brady owns 6 companies in total, including Spring Bank Pharmaceuticals Inc (SBPH) , Avidity Biosciences Inc (RNA) , and Evoke Pharma Inc (EVOK) among others .
Insider Ownership Summary of Todd C Brady
|Ticker||Comapny||Transaction Date||Type of Owner|
|SBPH||Spring Bank Pharmaceuticals Inc||2020-09-30||director|
|RNA||Avidity Biosciences Inc||2020-06-11||director|
|EVOK||Evoke Pharma Inc||2013-09-24||director|
|ALDX||Aldeyra Therapeutics Inc||2016-03-16||director & President and CEO|
|OTLK||Outlook Therapeutics Inc||2016-05-12||director|
|FSTX||F-star Therapeutics Inc||2016-11-23||director|
Todd C Brady Latest Holdings Summary
Todd C Brady currently owns a total of 1 stock. Todd C Brady owns 1,216,535 shares of Aldeyra Therapeutics Inc (ALDX) as of June 23, 2022, with a value of $8 Million.
Todd C Brady Form 4 Trading Tracker
According to the SEC Form 4 filings, Todd C Brady has made a total of 8 transactions in Aldeyra Therapeutics Inc (ALDX) over the past 5 years, including 8 buys and 0 sells. The most-recent trade in Aldeyra Therapeutics Inc is the acquisition of 17,700 shares on June 23, 2022, which cost Todd C Brady around $59,472.
Insider Trading History of Todd C Brady
Todd C Brady Trading Performance
GuruFocus tracks the stock performance after each of Todd C Brady's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Todd C Brady is -6.43%. GuruFocus also compares Todd C Brady's trading performance to market benchmark return within the same time period. The performance of stocks bought by Todd C Brady within 3 months outperforms 2 times out of 9 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Todd C Brady's insider trading performs compared to the benchmark.
Performance of Todd C Brady
|1 Month||3 Months||6 Months||1 Year||2 Years||3 Years|
|Relative Return to S&P 500(%)||7.79||-7.82||-24.53||24.02||2.04||-6.47|
Todd C Brady Ownership Network
Ownership Network List of Todd C Brady
Ownership Network Relation of Todd C Brady
Todd C Brady Owned Company Details
What does Spring Bank Pharmaceuticals Inc do?
Spring Bank Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is engaged in the discovery and development of therapeutics using proprietary small molecule nucleic acid hybrid or SMNH, chemistry platform. These SMNH products can be used for the treatment of viral disease including hepatitis B virus.
Who are the key executives at Spring Bank Pharmaceuticals Inc?
Todd C Brady is the director of Spring Bank Pharmaceuticals Inc. Other key executives at Spring Bank Pharmaceuticals Inc include VP of Finance and Treasurer Lori Firmani , director & President and CEO Martin J Driscoll , and Chief Scientific Officer Radhakrishnan P. Iyer .
Spring Bank Pharmaceuticals Inc (SBPH) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Spring Bank Pharmaceuticals Inc (SBPH) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Spring Bank Pharmaceuticals Inc (SBPH)'s detailed insider trading history can be found in Insider Trading Tracker table.
Spring Bank Pharmaceuticals Inc Insider Transactions
Todd C Brady Mailing Address
Above is the net worth, insider trading, and ownership report for Todd C Brady. You might contact Todd C Brady via mailing address: C/o Evoke Pharma, Inc., 505 Lomas Santa Fe Drive, Solana Beach Ca 92075.